Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai-Min Chu

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Stroke|April 23, 2011
Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 27, 2010
Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitorsGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Circulation|November 18, 2009
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial"Li-Ping Kan, Kai-Min Chu, Gen-Min Lin
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 27, 2010
The modulatory mechanisms of fenofibrate on human primary T cellsShu-Meng Cheng, Kai-Min Chu, Jenn-Haung Lai
Circulation|February 24, 2010
Letter by Lin et al regarding article, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
American Heart Journal|September 10, 2010
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
JAMA|November 25, 2010
Elective intra-aortic balloon pump placement in high-risk percutaneous coronary interventionGen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 25, 2010
Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation modelsGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Circulation|June 23, 2010
Letter by Lin et al regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 25, 2010
The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortalityGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Stroke|April 23, 2011
Letter by Lin et al regarding article, "Hepatitis C virus infection and increased risk of cerebrovascular disease"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 27, 2010
Pexelizumab may be hazardous to those with ST-segment elevation myocardial infarction undergoing primary percutaneous interventions without using glycoprotein IIb-IIIa inhibitorsGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Circulation|November 18, 2009
Letter by Kan et al regarding Article, "randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart failure (WATCH) trial"Li-Ping Kan, Kai-Min Chu, Gen-Min Lin
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 27, 2010
The modulatory mechanisms of fenofibrate on human primary T cellsShu-Meng Cheng, Kai-Min Chu, Jenn-Haung Lai
Circulation|February 24, 2010
Letter by Lin et al regarding article, "Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
American Heart Journal|September 10, 2010
Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry)Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
JAMA|November 25, 2010
Elective intra-aortic balloon pump placement in high-risk percutaneous coronary interventionGen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 25, 2010
Reverse epidemiology reflects C-reactive protein as a bystander of atherosclerosis in established systemic inflammation modelsGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Circulation|June 23, 2010
Letter by Lin et al regarding article, "Heart rate predicts outcomes in an implantable cardioverter-defibrillator population"Gen-Min Lin, Kai-Min Chu, Chih-Lu Han
International Journal of Cardiology|November 25, 2010
The influence of inflammation outweighing the metabolic syndrome on cardiovascular risk and mortalityGen-Min Lin, Kai-Min Chu, Chih-Lu Han
Pageof 3